» Authors » Derek J Bays

Derek J Bays

Explore the profile of Derek J Bays including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 183
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thompson 3rd G, Sani G, Donnelley M, Figueroa J, Ciuffetelli R, Trigg K, et al.
Antimicrob Agents Chemother . 2025 Jan; 69(3):e0169224. PMID: 39882912
Infusion reactions (tachycardia, hypertension, fever, etc.) associated with liposomal amphotericin B are common. Animal models have found complement activation responsible, yet the pathophysiology has not been evaluated in human patients....
2.
Lee J, Bays D, Savage H, Baumler A
Infect Immun . 2024 Sep; 92(11):e0030224. PMID: 39347570
The gut microbiome, composed of the colonic microbiota and their host environment, is important for many aspects of human health. A gut microbiome imbalance (gut dysbiosis) is associated with major...
3.
Bays D, Jenkins E, Lyman M, Chiller T, Strong N, Ostrosky-Zeichner L, et al.
Clin Epidemiol . 2024 Sep; 16:549-566. PMID: 39219747
Invasive candidiasis (IC) is an increasingly prevalent, costly, and potentially fatal infection brought on by the opportunistic yeast, . Previously, IC has predominantly been caused by which is often drug...
4.
Rogers A, Radlinski L, Nguyen H, Tiffany C, Carvalho T, Masson H, et al.
Cell Host Microbe . 2024 Aug; 32(10):1774-1786.e9. PMID: 39181125
The gut microbiota prevents harmful microbes from entering the body, a function known as colonization resistance. The enteric pathogen Salmonella enterica serovar (S.) Typhimurium uses its virulence factors to break...
5.
Savage H, Bays D, Tiffany C, Gonzalez M, Bejarano E, Carvalho T, et al.
Cell Host Microbe . 2024 Jun; 32(7):1103-1113.e6. PMID: 38838675
Antibiotic treatment promotes the outgrowth of intestinal Candida albicans, but the mechanisms driving this fungal bloom remain incompletely understood. We identify oxygen as a resource required for post-antibiotic C. albicans...
6.
Heidari A, Kaur S, Pearson S, Munoz A, Sandhu H, Mann G, et al.
Open Forum Infect Dis . 2024 Feb; 11(2):ofad679. PMID: 38370292
Background: Severe coccidioidomycosis presenting with respiratory failure is an uncommon manifestation of disease. Current knowledge of this condition is limited to case reports and small case series. Methods: A retrospective...
7.
Bryan Jr A, Sykes J, Crucillo K, Zhang K, Bays D, Cohen S, et al.
Med Mycol . 2023 Dec; 62(1). PMID: 38061838
The incidence of coccidioidomycosis continues to increase. The diagnosis frequently relies on non-invasive diagnostic testing with immunodiffusion and complement fixation (CF) testing the current gold standard. A direct comparison of...
8.
Savage H, Bays D, Gonzalez M, Bejarano E, Nguyen H, Masson H, et al.
bioRxiv . 2023 May; PMID: 37131682
Antibiotic prophylaxis sets the stage for an intestinal bloom of , which can progress to invasive candidiasis in patients with hematologic malignancies. Commensal bacteria can reestablish microbiota-mediated colonization resistance after...
9.
Shemuel J, Bays D, Thompson G, Reef S, Snyder L, Freifeld A, et al.
Med Mycol . 2022 Sep; 60(10). PMID: 36166843
There are still many limitations related to the understanding of the natural history of differing forms of coccidioidomycosis (CM), including characterizing the spectrum of pulmonary disease. The historical Veterans Administration-Armed...
10.
Hsu A, Korzeniowska A, Aguilar C, Gu J, Karlins E, Oler A, et al.
JCI Insight . 2022 Sep; 7(22). PMID: 36166305
Disseminated coccidioidomycosis (DCM) is caused by Coccidioides, pathogenic fungi endemic to the southwestern United States and Mexico. Illness occurs in approximately 30% of those infected, less than 1% of whom...